J&J pauses Covid-19 vaccine trials after unexplained illness in participant
The trials affected by the event include the phase 3 ENSEMBLE trial for JNJ-78436735
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Oct 20
The trials affected by the event include the phase 3 ENSEMBLE trial for JNJ-78436735
21 Jul 20
The Covid-19 vaccine is currently under development and the agreement with the UK government is subject to clinical…
17 Jul 20
J&J is preparing to start human trials of its Covid-19 vaccine this month and is working to accelerate…
08 Jul 20
The funding will support the late-stage clinical development, including pivotal Phase 3 clinical trial to support licensure and…
07 Jul 20
CureVac has reached a loan agreement with EIB for the development and production of vaccine candidate against SARS-CoV-2
17 Jun 20
The investment is aimed at strengthening Sanofi’s capability to advance the research and production of new advanced vaccines
25 May 20
Despite the rapid growth in demand for drugs, the pharma industry has not kept pace - meaning it…
Pharmaceuticals and MedicinesContract ManufacturingPharmaceuticals
19 May 20
The range of packaging options can be overwhelming for companies trying to navigate formats in conjunction with regulations…
The experience of adapting to new challenges for the cold chain may well prove vital when pharmaceutical companies…
FacilitiesPharmaceuticals and MedicinesClinical supplies and logistics
21 Apr 20
Multiple sclerosis is a chronic disease that occurs when the immune system abnormally attacks the parts of nerve…